Benzinga | Dec 7, 2021 04:58AM EST

Cowen & Co. Initiates Coverage On CRISPR Therapeutics with Market Perform Rating

Cowen & Co. analyst Tyler Van Buren initiates coverage on CRISPR Therapeutics (NASDAQ:CRSP) with a Market Perform rating.